Abstract:TRF2 is a telomere-binding protein involved in the protection of chromosome ends. Interestingly, TRF2 is overexpressed in a number of human cancers. Mice with increased TRF2 expression (K5TRF2 mice) display a severe skin phenotype including an increase in skin cancer and premature skin degeneration, which includes increased skin hyperpigmentation and skin dryness; these pathologies are concomitant with dramatic telomere shortening and increased chromosomal instability. Here, we show that K5TRF2 mice have a severe epidermal stem cell (ESC) dysfunction, which is reversed by abrogation of p53 in the absence of rescue of telomere length. Importantly, p53 deletion also rescues severe skin hyperpigmentation in these mice through regulation of alpha-melanocyte-stimulating hormone (alpha-MSH). In addition, skin carcinogenesis is accelerated in K5TRF2/p53(-/-)mice owing to attenuated p21 induction, which enables cell proliferation to resume. Altogether, these results reveal the existence of a DNA damage-dependent checkpoint that acts on ESCs with critically short telomeres and restricts skin proliferation, thereby increasing protection against skin cancer; however, the checkpoint also leads to premature skin aging phenotypes. Finally, the results described here are relevant to our understanding of the pathobiology of those human diseases that are characterized by the presence of critically short telomeres (hereafter referred to as 'telopathies'), such as dyskeratosis congenita which causes severe skin phenotypes including skin hyperpigmentation and skin cancer.

Chk2-Independent Induction of Telomere Dysfunction Checkpoints in Stem and Progenitor Cells

Dual Induction of Apoptosis and Senescence in Cancer Cells by Chk2 Activation: Checkpoint Activation As a Strategy Against Cancer.

Mammalian DNA2 helicase/nuclease cleaves G-quadruplex DNA and is required for telomere integrity.

p21 deletion rescues stem cell senescence and premature ageing of telomere dysfunctional mice without accelerating cancer formation

The cellular level of telomere dysfunction determines induction of senescence or apoptosis in vivo.

A DNA damage checkpoint response in telomere-initiated senescence

Cross-Talk Between Chk1 And Chk2 In Double-Mutant Thymocytes

Nek4 Regulates Entry into Replicative Senescence and the Response to DNA Damage in Human Fibroblasts.

Reciprocal regulation of p21 and Chk1 controls the Cyclin D1-RB pathway to mediate senescence onset after DNA damage-induced G2 arrest

Cdkn1a Deletion Improves Stem Cell Function and Lifespan of Mice with Dysfunctional Telomeres Without Accelerating Cancer Formation

Telomere Dysfunction and Cell Cycle Checkpoints in Hematopoietic Stem Cell Aging

Mammalian Chk2 is a Downstream Effector of the ATM-dependent DNA Damage Checkpoint Pathway

Atm-Chk2-P53 Activation Prevents Tumorigenesis At An Expense Of Organ Homeostasis Upon Brca1 Deficiency

The CHK2–BRCA1 tumour suppressor pathway ensures chromosomal stability in human somatic cells

Telomere Checkpoint in Development and Aging

Chk1 Regulates the S Phase Checkpoint by Coupling the Physiological Turnover and Ionizing Radiation-Induced Accelerated Proteolysis of Cdc25A.

Puma and P21 Represent Cooperating Checkpoints Limiting Self-Renewal and Chromosomal Instability of Somatic Stem Cells in Response to Telomere Dysfunction.

Genetic dissection of the mechanisms underlying telomere-associated diseases: impact of the TRF2 telomeric protein on mouse epidermal stem cells

Genetic Instability and Mammary Tumor Formation in Mice Carrying Mammary-Specific Disruption of Chk1 and P53

Cdk phosphorylation of Chk1 regulates efficient Chk1 activation and multiple checkpoint proficiency

Telomeres and telomerase in stem cells during aging and disease.